Microbiota Transplant and Gynecological Disorders: The Bridge between Present and Future Treatments

Abstract

Fecal microbiota transplantation (FMT) is a procedure that involves transferring fecal bacteria from a healthy donor to a patients’ intestines to restore gut–immunity homeostasis. While FMT was primarily supposed to treat gastrointestinal disorders such as inflammatory bowel disease and irritable bowel syndrome—and especially Clostridium difficile infection (currently the only used as clinical treatment)—recent research has suggested that it may also become a potential treatment for gynecological disorders, including endometriosis and polycystic ovary syndrome (PCOS). On the contrary, vaginal microbiota transplantation (VMT) is a newer and less commonly used procedure than the FMT approach, and its potential applications are still being explored. It involves direct grafting of the entire vaginal microbiota of healthy women into the vaginal tract of patients to easily rebuild the local microbiota environment, restoring vaginal eubiosis and relieving symptoms. Like FMT, VMT is thought to have potential in treating different microbiota-related conditions. In fact, many gynecological disorders, such as bacterial vaginosis and vulvovaginal candidiasis, are thought to be caused by an imbalance in the vaginal microbiota. In this review, we will summarize the development, current challenges, and future perspectives of microbiota transplant, with the aim of exploring new strategies for its employment as a promising avenue for treating a broad range of gynecological diseases.

Mechanisms of probiotic modulation of ovarian sex hormone production and metabolism: a review

“…191 Oral probiotics appear to play a key role in regulating vaginal conditions via inhibiting the expression of vaginal pro-inflammatory cytokines and ultimately regulating the composition of the vaginal microbiota, as brilliantly described in a paper by Martinelli. 192…”

The Impact of Microbiota–Immunity–Hormone Interactions on Autoimmune Diseases and Infection

“…Overall, the microbiome–hormone interactions play a critical role in modulating the immune system’s activity and function, and alterations in hormones’ levels or signaling can contribute to the development and progression of autoimmune diseases. Further research is needed to elucidate the specific mechanisms involved and to develop novel therapeutic strategies based on hormone modulation by manipulating the microbiota, including fecal microbiota transplantation (FMT) [ 229 ].…”

The modern pathogenetic challenges of polycystic ovary syndrome

“…Recently, the use of the supplements with gut or vaginal microbiota is one of the treatment approaches for gynecological disease which are caused by vaginal microbiota dysbalance including endometriosis and PCOS [73].…”